Can Stress Echocardiography Compete with Perfusion Scintigraphy in the Detection of Coronary Artery Disease and Cardiac Risk Assessment?

European Journal of Echocardiography

Volumn 1, Issue 1, 2000, Pages 12-21

  Geleijnse, M L ^a   Elhendy, A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Coronary artery disease; Diagnosis; Stress echocardiography; Risk assessment

Indexed keywords

DIAGNOSTIC AGENT; DOBUTAMINE;

CORONARY ARTERY DISEASE; ECHOGRAPHY; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; MALE; PROGNOSIS; REVIEW; RISK ASSESSMENT; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY;

CORONARY DISEASE; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; HYPERTENSION; MALE; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0034148894     PISSN: 15252167     EISSN: None     Source Type: Journal    
DOI: 10.1053/euje.2000.0008     Document Type: Article

References (74)

1. Wann LS, Faris JV, Childress RH, Dillon JC, Weyman AE, Feigenbaum H. Exercise cross-sectional echocardiography in ischemic heart disease. Circulation. 60:1979;1300-1308.
2. Maurer G, Nanda NC. Two dimensional echocardiographic evaluation of exercise-induced left and right ventricular asynergy: correlation with thallium scanning. Am J Cardiol. 48:1981;720-727.
3. Pozzoli MMA, Fioretti PM, Salustri A, Reijs AE, Roelandt JRTC. Exercise echocardiography and technetium-99m MIBI single-photon emission computed tomography in the detection of coronary artery disease. Am J Cardiol. 67:1991;350-355.
4. Galanti G, Sciagrà R, Comeglio M. Diagnostic accuracy of peak exercise echocardiography in coronary artery disease: Comparison with thallium-201 myocardial scintigraphy. Am Heart J. 122:1991;1609-1616.
5. Quiñones MA, Verani MS, Haichin RM, Mahmarian JJ, Suarez J, Zoghbi WA. Exercise echocardiography versus Thallium-201 single-photon emission computed tomography in evaluation of coronary artery disease. Analysis of 292 patients. Circulation. 5:1992;1026-1031.
6. Salustri A, Pozzoli MMA, Hermans W. Relation between exercise echocardiography and perfusion single-photon emission computed tomography in patients with single-vessel coronary artery disease. Am Heart J. 124:1992;75-83.
7. Hecht HS, Debord L, Shaw R, Chin H, Dunlap R, Ryan C, Myler RK. Supine bicycle stress echocardiography versus tomographic thallium-201 exercise imaging for the detection of coronary artery disease. J Am Soc Echocardiogr. 6:1993;177-185.
8. Günalp B, Dokumaci B, Uyan C. Value of dobutamine Technetium-99m-Sestamibi SPECT and echocardiography in the detection of coronary artery disease compared with coronary angiography. J Nucl Med. 34:1993;889-894.
9. Marwick T, D'Hondt A, Baudhuin T, Willemart B, Wijns W, Detry JM, Melin J. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both. J Am Coll Cardiol. 22:1993;159-167.
10. Forster T, McNeill AJ, Salustri A, Reijs AE, El-Said ES, Roelandt JRTC, Fioretti PM. Simultaneous dobutamine stress echocardiography and 99m-technetium isonitrile single photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol. 21:1993;1591-1596.
11. Senior R, Sridhara BS, Anagnostou E, Handler C, Raftery EB, Lahiri A. Synergistic value of simultaneous stress dobutamine sestamibi single-photon emission computerized tomography and echocardiography in the detection of coronary artery disease. Am Heart J. 128:1994;713-718.
12. Di Bello V, Bellina CR, Gori E. Incremental diagnostic value of dobutamine stress echocardiography and dobutamine scintigraphy (technetium 99m-labeled sestamibi single-photon emission computed tomography) for assessment of presence and extent of coronary artery disease. J Nucl Cardiol. 3:1996;212-220.
13. Kisacik HL, Özdemir K, Altinyay E. Comparison of exercise stress testing with simultaneous dobutamine stress echocardiography and technetium-99M isonitrile single-photon emission computerized tomography for the diagnosis of coronary artery disease. Eur Heart J. 17:1996;113-119.
14. Huang PJ, Ho YL, Wu CC. Simultaneous dobutamine stress echocardiography and thallium perfusion imaging for the detection of coronary artery disease. Cardiology. 88:1997;556-562.
15. Santoro GM, Sciagrà R, Buonamici P. Head-to-head comparison of exercise stress testing, pharmacologic stress echocardiography, and perfusion tomography as first-line examination for chest pain in patients without a history of coronary artery disease. J Nucl Cardiol. 5:1998;19-27.
16. Nguyen T, Heo J, Ogilby JD, Iskandrian AS. Single photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemie: correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography. J Am Coll Cardiol. 16:1990;1375-1383.
17. Amanullah AM, Bevegard S, Lindvall K, Aasat M. Assessment of left ventricular wall motion in angina pectoris by two dimensional echocardiography and myocardial perfusion by technetium-99m sestamibi tomography during adenosine-induced coronary vasodilation and comparison with coronary angiography. Am J Cardiol. 72:1993;983-989.
18. Marwick T, Willemart B, D'Hondt AM. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99m Tc-MIBI single photon emission computed tomography. Circulation. 87:1993;345-354.
19. Ferrara N, Bonaduce D, Leosco D. Two-dimensional echocardiographic evaluation of ventricular asynergy induced by dipyridamole: correlation with thallium scanning. Clin Cardiol. 9:1986;437-442.
20. Perin EC, Moore W, Blume M, Hernandez G, Dhekne R, DeCastro M. Comparison of dipyridamole echocardiography with dipyridamole thallium scintigraphy for the diagnosis of myocardial ischemia. Clin Nucl Med. 16:1991;417-420.
21. Parodi G, Picano E, Marcassa C. High dose dipyridamole myocardial imaging: simultaneous scintigraphy and two-dimensional echocardiography in the detection and evaluation of coronary artery disease. Coron Art Dis. 10:1999;177-184.
22. Van Daele M, McNeill AJ, Fioretti PM. Prognostic value of dipyridamole sestamibi single-photon emission computed tomography and dipyridamole stress echocardiography for new cardiac events after an uncomplicated myocardial infarction. J Am Soc Echocardiogr. 7:1994;370-380.
23. Geleijnse ML, Elhendy A, Cornel JH. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? Circulation. 96:1997;137-147.
24. Olmos LI, Dakik H, Gordon R. Long-term prognostic value of exercise echocardiography compared with exercise 201T1, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation. 98:1998;2679-2686.
25. Van Damme H, Piérard L, Gillain D, Benoit TH, Rigo P, Limet R. Cardiac risk assessment before vascular surgery: a prospective study comparing clinical evaluation, dobutamine stress echocardiography, and dobutamine Tc-99m sestamibi tomoscintigraphy. Cardiovasc Surg. 5:1997;54-64.
26. Pasquet A, D'Hondt AM, Verhelst R, Vanoverschelde JL, Melin J, Marwick TH. Comparison of dipyridamole stress echocardiography and perfusion scintigraphy for cardiac risk stratification in vascular surgery patients. Am J Cardiol. 82:1998;1468-1474.
27. Nesto RW, Kowalchuck GJ. The ischemic cascade: Temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol. 57:1987;23C-27C.
28. Leppo JA, Meerdink DA. Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium. Circ Res. 64:1989;632-639.
29. Picano E, Lattanzi F, Orlandini A, Marini C, L'Abbate A. Stress echocardiography and the human factor: the importance of being expert. J Am Coll Cardiol. 24:1991;928-933.
30. Varga A, Picano E, Dodi C, Barbieri L, Pratali L, Gaddi O. Madness and method in stress echo reading. Eur Heart J. 20:1999;1271-1275.
31. Hoffmann R, Lethen H, Marwick T. Analysis of interinstitutional observer agreement in the interpretation of dobutamine stress echocardiogram. J Am Coll Cardiol. 27:1996;330-336.
32. Pennel DJ, Ell PJ. Whole-body imaging of thallium-201 after six different stress regimens. J Nucl Med. 35:1994;425-428.
33. Casanova R, Petroncini A, Guidotti PL, Capacci PF, Jacopi F, Fabbri M, Maresta A. Dose and test for dipyridamole infusion and cardiac imaging early after uncomplicated acute myocardial infarction. Am J Cardiol. 70:1992;1402-1406.
34. Picano E, Pingitore A, Conti U. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography. Eur Heart J. 14:1993;1216-1222.
35. Fung AY, Gallagher KP, Buda AJ. The physiologic basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis. Circulation. 76:1987;943-951.
36. Geleijnse ML, Marwick TH, Boersma E, Deckers JW, Melin JA, Fioretti PM. Optimal pharmacological stress testing for the diagnosis of coronary artery disease: a probabilistic approach. Eur Heart J. 16:1995;3-10.
37. Lee J, Chae SC, Lee K, Heo J, Iskandrian AS. Biokinetics of thallium-201 in normal subjects: comparison between adenosine, dipyridamole, dobutamine and exercise. J Nucl Med. 35:1994;535-541.
38. Smart, SC, Bhatia, N, Stoiber, T, Dobutamine-atropine stress echocardiography and dipyridamole sestamibi scintigraphy for the detection of coronary artery disease: limitations and concordance, J Am Coll Cardiol.
39. Ho FM, Huang PJ, Liau CS, Lee FK, Chieng PU, Su CT, Lee YT. Dobutamine stress echocardiography compared with dipyridamole thallium-201 single-photon emission computed tomography in detecting coronary artery disease. Eur Heart J. 16:1995;570-575.
40. Califf RM, Harrell FE Jr, Lee KL. The evolution of medical and surgical therapy for coronary artery disease: a 15-year perspective. JAMA. 67:1989;302-309.
41. Hirzel HO, Senn M, Nuessch K, Bettner C, Pfeiffer A, Hess OM, Krayenbuehl HP. Thallium-201 scintigraphy in complete left bundle branch block. Am J Cardiol. 53:1984;764-769.
42. Ono S, Nohara R, Kambara H, Okuda K, Kawai C. Regional myocardial perfusion and glucose metabolism in experimental left bundle branch block. Circulation. 85:1995;1125-1131.
43. Olsson RA, Bunger R. Metabolic control of coronary flow. Prog Cardiovasc Dis. 29:1987;369-387.
44. O'Keefe J, Bateman TM, Barnhart CS. Adenosine thallium-201 is superior to exercise thallium-201 for detecting coronary artery disease in patients with left bundle branch block. J Am Coll Cardiol. 21:1993;1332-1338.
45. Mairesse GH, Marwick TH, Arnese M. Improved identification of coronary artery disease in patients with left bundle branch block by use of dobutamine stress echocardiography and comparison with myocardial perfusion tomography. Am J Cardiol. 76:1995;321-325.
46. Geleijnse ML, Vigna C, Kasprzak JD. Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block. A multicenter study. Eur Heart J. 2000.
47. Schulman DS, Francis CK, Black HR, Wackers FJT. Thallium-201 stress imaging in hypertensive patients. Hypertension. 10:1987;16-21.
48. DePuey EG, Guertler-Krawczynska E, Perkins JV, Robbins WL, Whelchel JD, Clements SD. Alterations in myocardial thallium-201 distribution in patients with chronic systemic hypertension undergoing 201 single-photon emission computed tomography. Am J Cardiol. 62:1988;234-238.
49. Houghton JL, Frank MJ, Car AA, Von Dohlen TW, Prisant LM. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol. 15:1990;43-51.
50. Tomanek RJ. Response of the coronary vasculature to myocardial hypertrophy. J Am Coll Cardiol. 15:1990;528-533.
51. Picano E, Lucarini AR, Lattanzi F, Distante A, Legge VD, Salvetti A, L'Abbate A. Dipyridamole echocardiography in essential hypertension patients with chest pain. Hypertension. 12:1988;238-243.
52. Marwick TH, Torelli J, Harjai K, Haluska B, Pashkow F, Stewart WJ, Thomas JD. Influence of left ventricular hypertrophy on detection of coronary artery disease using exercise echocardiography. J Am Coll Cardiol. 26:1995;1180-1186.
53. Fragasso G, Lu C, Dabrowski P, Pagnotta P, Sheiban I, Chierchia SL. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test. J Am Coll Cardiol. 34:1999;441-447.
54. Elhendy A, Van Domburg RT, Roelandt JRTC, Geleijnse ML, Mohsen Ibrahim M, Fioretti PM. Safety and feasibility of dobutamine-atropine stress testing in hypertensive patients. Hypertension. 29:1997;1232-1239.
55. Senior R, Basu S, Handler C, Raftery EB, Lahiri A. Diagnostic accuracy of dobutamine stress echocardiography for detection of coronary heart disease in hypertensive patients. Eur Heart J. 17:1996;289-295.
56. Elhendy A, Geleijnse ML, Van Domburg RT. Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy. Eur J Nucl Med. 25:1998;69-78.
57. Ho YL, Wu CC, Lin LC. Assessment of the coronary artery disease and systolic dysfunction in hypertensive patients with dobutamine-atropine stress echocardiography: effect of the left ventricular hypertrophy. Cardiology. 89:1998;52-58.
58. Chaitman BR, Bourassa MG, Davis K. Angiographic prevalence of high risk coronary artery disease in patients subsets (CASS). Circulation. 64:1981;360-367.
59. Gordon DePuey G, Garcia EV. Optimal specificity of thallium-201 SPECT through recognition of imaging artifacts. J Nucl Med. 30:1989;441-449.
60. Hansen CL, Crabbe D, Rubin S. Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women: an effect of smaller chamber size. J Am Coll Cardiol. 28:1996;1214-1219.
61. Masini M, Picano E, Lattanzi F, Distante A, L'Abbate A. High dose dipyridamole-echocardiography test in women: correlation with exercise-echocardiography test and coronary arteriography. J Am Coll Cardiol. 12:1988;682-685.
62. Marwick TH, Anderson T, Williams MJ. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol. 26:1995;335-341.
63. Elhendy A, Geleijnse ML, Van Domburg RT. Gender differences in the accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery disease. Am J Cardio. 80:1997;1414-1418.
64. Takeuchi M, Sonoda S, Miura Y, Kuroiwa A. Comparative diagnostic value of dobutamine stress echocardiography and stress thallium-201 single-photon emission computed tomography for detecting coronary artery disease in women. Coron Art Dis. 7:1996;831-835.
65. 99mTc sestamibi single-photon emission CT. Chest. 114:1998;1097-1104.
66. Ho YL, Wu CC, Huang PJ. Assessment of coronary artery disease in women by dobutamine stress echocardiography: comparison with stress thallium-201 single-photon emission computed tomography and exercise electrocardiography. Am Heart J. 135:1998;655-662.
67. Marwick TH. Current status of stress echocardiography for diagnosis and prognostic assessment of coronary artery disease. Coron Art Dis. 9:1998;411-426.
68. Marwick TH, D'Hondt AM, Mairesse GH, Baudhuin T, Wijns W, Detry JM, Melin JA. Comparative ability of dobutamine and exercise stress in inducing myocardial ischemia in active patients. Br Heart J. 72:1994;31-38.
69. Hutchinson SJ, Shen A, Soldo S, Hla A, Kawanishi DT, Chandraratna AN. Transesophageal assessment of coronary flow velocity reserve during 'regular' and 'high'-dose dipyridamole stress testing. Am J Cardiol. 77:1996;1164-1168.
70. McNeill AJ, Fioretti PM, El-Said EM, Salustri A, Forster R, Roelandt JRTC. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol. 70:1992;41-46.
71. Spencer KY, Bednarz J, Rafter PG, Korcarz C, Lang RM. Use of harmonic imaging without echocardiographic contrast to improve two-dimensional image quality. Am J Cardiol. 82:1998;794-799.
72. Porter TR, Xie F, Kricsfeld A, Chiou A, Dabestani A. Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin. J Am Coll Cardiol. 23:1994;1440-1443.
73. Koch R, Lang RM, Garcia MJ. Objective evaluation of regional left ventricular wall motion during dobutamine stress echocardiographic studies using segmental analysis of color kinesis images. J Am Coll Cardiol. 34:1999;409-419.
74. Sutherland GR, Stewart MJ, Groundstroem KWE. Color Doppler myocardial imaging: A new technique for the assessment of myocardial function. J Am Soc Echocardiogr. 7:1994;441-458.